APA (7th ed.) Citation

Campagne, O., Ilic, K., Gabriel, A., Sueda, K., Ye, R., Zhang, F., . . . Sun, K. (2025). A Phase 1, Open‐Label, Randomized, Two‐Part Study in Healthy Adult Volunteers to Evaluate the Bioavailability of the Maribavir Powder for Oral Suspension, as Well as Food Effect and Impact of Rabeprazole. Clinical Pharmacology in Drug Development, 14(2), 133. https://doi.org/10.1002/cpdd.1493

Chicago Style (17th ed.) Citation

Campagne, Olivia, Katarina Ilic, Andre Gabriel, Katsuhiko Sueda, Ran Ye, Fangqiu Zhang, Peixin Xu, Hnin Hnin Ko, and Kefeng Sun. "A Phase 1, Open‐Label, Randomized, Two‐Part Study in Healthy Adult Volunteers to Evaluate the Bioavailability of the Maribavir Powder for Oral Suspension, as Well as Food Effect and Impact of Rabeprazole." Clinical Pharmacology in Drug Development 14, no. 2 (2025): 133. https://doi.org/10.1002/cpdd.1493.

MLA (9th ed.) Citation

Campagne, Olivia, et al. "A Phase 1, Open‐Label, Randomized, Two‐Part Study in Healthy Adult Volunteers to Evaluate the Bioavailability of the Maribavir Powder for Oral Suspension, as Well as Food Effect and Impact of Rabeprazole." Clinical Pharmacology in Drug Development, vol. 14, no. 2, 2025, p. 133, https://doi.org/10.1002/cpdd.1493.